Paper Details

  1. Home
  2. Paper Details

[First fixed dose combination perindopril arginine-indapamide-amlodipine: new approach in combination therapy in hypertension].

Author: WidimskýJiří

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
English AbstractA summary of a research paper/publication written in English for a wider audience.

Overview

Fixed combination antihypertensive therapy improves compliance, blood pressure control, and prognosis. Triplixam®, a fixed combination of perindopril arginine, indapamide, and amlodipine, has shown significant antihypertensive effects and good tolerance.
Paper Details　
Original Abstract of the Article :
Use of fixed combination of antihypertensive drugs clearly improves compliance to the pharmacological therapy, control of hypertension and prognosis. Based on the current guidelines triple antihypertensive therapy with RAS-blocker, calcium channel blocker (CCB) and diuretic represents the standard a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/25294773

データ提供：米国国立医学図書館（NLM）

Unlocking the Power of Triple Therapy in Hypertension

High blood pressure, a silent threat lurking in the shadows, affects millions globally. While many medications exist, managing this condition effectively requires a multifaceted approach. This study, much like finding a hidden spring in a desolate desert, delves into the effectiveness of a new fixed triple combination drug therapy for hypertension.

A Triple Threat to Hypertension

The authors explore the benefits of combining perindopril arginine, indapamide, and amlodipine in one pill, a convenient and effective solution. This combination is like a team of experienced travelers, each bringing unique strengths to tackle the challenges of hypertension. The study highlights the potential of this triple therapy for patients with uncontrolled blood pressure, especially those already on multiple medications.

Improved Control and Prognosis: A Positive Outlook

The study emphasizes the positive impact of this new drug combination on both blood pressure control and long-term prognosis, offering a glimmer of hope for patients facing this chronic condition.

Dr. Camel's Conclusion

This study sheds light on a potential breakthrough in hypertension management. The combination of perindopril arginine, indapamide, and amlodipine in a fixed-dose formulation offers a streamlined approach to control blood pressure, improve patient compliance, and potentially enhance long-term outcomes.

Date :
  1. Date Completed n.d.
  2. Date Revised 2019-11-20
Further Info :

Pubmed ID

25294773

DOI: Digital Object Identifier

49817

SNS
PICO Info
in preparation
Languages

Czech

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.